Cargando…
Effects of hydroxychloroquine on atrial electrophysiology in in silico wild-type and PITX2(+/-) atrial cardiomyocytes
BACKGROUND: Hydroxychloroquine (HCQ) is commonly used in the treatment of autoimmune diseases and increases the risk of QT interval prolongation. However, it is unclear how HCQ affects atrial electrophysiology and the risk of atrial fibrillation (AF). METHODS: We quantitatively examined the potentia...
Autor principal: | Song, Euijun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Medizin
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9894744/ https://www.ncbi.nlm.nih.gov/pubmed/36732468 http://dx.doi.org/10.1007/s00059-023-05162-w |
Ejemplares similares
-
In Silico Assessment of Class I Antiarrhythmic Drug Effects on Pitx2-Induced Atrial Fibrillation: Insights from Populations of Electrophysiological Models of Human Atrial Cells and Tissues
por: Bai, Jieyun, et al.
Publicado: (2021) -
In silico investigation of the mechanisms underlying atrial fibrillation due to impaired Pitx2
por: Bai, Jieyun, et al.
Publicado: (2020) -
Reduced left atrial cardiomyocyte PITX2 and elevated circulating BMP10 predict atrial fibrillation after ablation
por: Reyat, Jasmeet S., et al.
Publicado: (2020) -
PITX2 gain-of-function mutation associated with atrial fibrillation alters mitochondrial activity in human iPSC atrial-like cardiomyocytes
por: Benzoni, Patrizia, et al.
Publicado: (2023) -
Transgenic Insights Linking Pitx2 and Atrial Arrhythmias
por: Franco, Diego, et al.
Publicado: (2012)